TI-2023-27190 Aliases CVE-2023-49780 GHSA-wfv9-phg2-7v54

Cross-site scripting in Extra Innovation Inc. acmailer CGI

LOW 27CWE-79Published 2025-02-12 · Updated 2025-02-18

Key facts

Attack vector: Network
Privileges required: None
User interaction: Required
Attack complexity: Low
Impact type: Cross-site scripting
Confidentiality · integrity · availability: Low · Low · None
Fix status: No fix listed

Attack profile from CVSS 3.0 · CNA. Fix status from CNA. Impact type from CWE-79.

Summary

Cross-site scripting vulnerability exists in acmailer CGI ver.4.0.5 and earlier. An arbitrary script may be executed on the web browser of the user who accessed the management page of the affected product.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV

EPSS 0.0029 21st percentileScored 2026-11-07

Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation: None
Automatable: No
Technical impact: Partial

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

Vendor	Product	Affected versions	Fixed in	Status	Source
Extra Innovation Inc.	acmailer CGI	ver.4.0.5 and earlier	—	No fix listed	CNA

acmailer CGI VendorExtra Innovation Inc. Affected ver.4.0.5 and earlier Fixed in — No fix listed CNA

Remediation

No fixed version listed by the sources yet.

Timeline

2026-10-02 Threatist record created from CVE-2023-49780
2026-10-03 Alias added: GHSA-wfv9-phg2-7v54

References

Other 2

TI-2021-21449 OS command injection in Extra Innovation Inc. acmailer CGI CVSS 3.0CRITICAL 9.8
TI-2026-49188 Incorrect authorization in Extra Innovation Inc. acmailer CGI CVSS 4.0HIGH 8.7
TI-2026-47132 A cross-site scripting vulnerability exists in acmailer, which may allow an attacker to execute an arbitrary script. CVSS 4.0MEDIUM 5.1

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences